Studies show that women with obesity are more likely to have irregular cycles
17 Recent advances in pharmacological treatments Sodium-glucose cotransporter-2 inhibitors SGLT-2 inhibitors (empagliflozin and dapagliflozin) are recommended in most people with type 2 diabetes and CKD, given the strong evidence that SGLT-2 inhibitors reduce CKD progression, heart failure and the risk of atherosclerotic CV disease in people with type 2 diabetes and CKD
Extra caution makes sense if you: Take blood thinners Take diabetes medication Take blood pressure medication Have asthma or chronic lung disease Have liver or kidney disease Are pregnant or breastfeeding Have surgery planned Take multiple supplements daily Supplements should support your routine, not make it confusing or risky
Does semaglutide interact with [metformin](/metformin) or other diabetes medications
* Correspondence: Omid Akbari, [email protected] Disclaimer All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers
Additionally, patients with pre-existing liver conditions should exercise caution with acetaminophen regardless of semaglutide use, as acetaminophen is metabolized by the liver
